Roundtable 1 - Current situation in each country & continent
17:40
25min
Roundtable 2 - Activity status: are you open or closed? What are your management strategies for your activities and your patients? What are the consequences so far?
18:05
25min
Roundtable 3 - Implications: financial, legal and marketing points of views
18:30
15min
Roundtable 4 - The future: how to organize and emerge from the crisis
Pioneer in regenerative aesthetics, Laboratoires VIVACY is a French manufacturer of premium hyaluronic acid-based medical devices, founded in 2007 and headquartered in Paris. Renowned for its proprietary IPN-Like Technology, the company is best known for STYLAGE® dermal fillers and DESIRIAL®, the world’s first injectable for functional and aesthetic gynaecology. VIVACY recently partnered with Burgeon Biotechnology on the CaHA-based biostimulator NOVUMA® and with ResearchPharma on the exclusive distribution of REJURAN® PN-based skin booster in Europe. With products manufactured at its high-tech facility in Archamps Technopole, France, VIVACY operates in over 85 countries with more than 350 employees worldwide.
Pioneer in regenerative aesthetics, Laboratoires VIVACY is a French manufacturer of premium hyaluronic acid-based medical devices, founded in 2007 and headquartered in Paris. Renowned for its proprietary IPN-Like Technology, the company is best known for STYLAGE® dermal fillers and DESIRIAL®, the world’s first injectable for functional and aesthetic gynaecology. VIVACY recently partnered with Burgeon Biotechnology on the CaHA-based biostimulator NOVUMA® and with ResearchPharma on the exclusive distribution of REJURAN® PN-based skin booster in Europe. With products manufactured at its high-tech facility in Archamps Technopole, France, VIVACY operates in over 85 countries with more than 350 employees worldwide.
Roundtable 1 - Current situation in each country & continent
17:40
25min
Roundtable 2 - Activity status: are you open or closed? What are your management strategies for your activities and your patients? What are the consequences so far?
18:05
25min
Roundtable 3 - Implications: financial, legal and marketing points of views
18:30
15min
Roundtable 4 - The future: how to organize and emerge from the crisis